Almitas Capital Portfolio Shifts in Q2 2026: Focus on Financial Services and Healthcare

Almitas Capital Llc has recently reported its portfolio holdings for the period ending June 30th, 2026. The fund's total value stands at $366,590,440 as of this date.

The investor's activity report highlights several key changes in their portfolio during Q2 2026 compared to the previous period:

• Significant Purchases: Almitas Capital showed a strong buying interest, particularly evident in the substantial increase of holdings in Aberdeen Munincipal Income Fund (MFM). The fund also increased its position significantly in Cornerstone Total Return Fund (CRF) and Pimco Dynamic Income Strategic Fund (PDX), indicating confidence in these Financial Services offerings. Furthermore, there was considerable buying activity in New York Life's CBRE Global Infrastructure Megatrends Fund (MEGI), with a nearly 76% increase in shares held.
• Major Sales: The investor divested substantial portions of their portfolio during the quarter. Holdings in Amylyx Pharmaceuticals Inc (AMLX) decreased by over 54%, representing one of the largest exits reported. Similarly, Design Therapeutics Inc (DSGN) saw a significant reduction of nearly 33% in its position.
• New Positions: The data indicates that Almitas Capital established new positions during this quarter with holdings in Liberty All-Star Equity Fund (USA), Liberty All-Star Growth Fund I (ASG), and Nuveen S&P 500 Dynamic Overweight Fund (XSSPX).
• Reduced Holdings: The investor also scaled down their exposure to several other funds, including Cornerstone Strategic Investments Inc (CLM) and ALX Oncology Holdings Inc (ALXO). Additionally, the fund completely exited its position in Playstudios Inc (MYPS), which experienced an 87.68% reduction.

These changes reflect a strategic rebalancing of Almitas Capital's portfolio during Q2 2026. The investor appears to be actively managing their holdings, both adding new positions and exiting existing ones based on performance or outlook.

The fund's sector allocation remains dominated by Financial Services (38.72%) and Unknown sectors (36.81%). While the largest disclosed sale was from Healthcare (specifically AMLX), there are still significant holdings in that sector, including positions in Amylyx Pharmaceuticals Inc (AMLX) at 4.2% allocation despite the large reduction.

For detailed information on Almitas Capital Llc's portfolio and its investment strategy, please visit their profile page here. You can explore specific holdings like the Aberdeen Munincipal Income Fund (MFM) at this link or learn more about Cornerstone Total Return Fund (CRF) here: here.